XML 34 R24.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders' Equity
 9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Equity Stockholders' Equity
Common Stock Plans
We have stock-based compensation plans under which restricted stock awards and stock options are outstanding or granted subject to time or performance vesting requirements. At September 30, 2025, approximately 0.6 million shares were available for future issuance under our current plan.
Quarter Ended September 30,Nine Months Ended September 30,
2025202420252024
Total stock-based compensation expense (income)$0.6 $(0.9)$4.1 $7.2 
Income tax provision (benefit) related to stock-based compensation$— $(0.5)$0.2 $0.8 
Impact on cash flow from proceeds on options exercised$— $0.2 $— $1.3 
Impact on cash flow due to taxes paid related to net share settlement of equity awards$— $0.1 $2.3 $4.1 
As of September 30, 2025, there was $10.8 million of total unrecognized compensation costs related to outstanding restricted stock unit awards.
During the nine months ended September 30, 2025, we granted 198,887 restricted stock units (time vesting) at an average grant date fair value of $28.36 per share and 194,378 restricted stock units (performance vesting) at an average grant date fair value of $31.04 per share.
During the quarter and nine months ended September 30, 2024, stock-based compensation income of $1.3 million and expense of $6.0 million was charged to continuing operations, and expense of $0.4 million and $1.2 million was charged to discontinued operations.